5,6-Dihydro-5,11-diketo-6-propyl-11H-indeno[1,2-c]isoquinoline | 81721-74-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 5,6-Dihydro-5,11-diketo-6-propyl-11H-indeno[1,2-c]isoquinoline
• 英文别名: 6-Propyl-5H-indeno(1,2-c)isoquinoline-5,11(6H)-dione；6-propylindeno[1,2-c]isoquinoline-5,11-dione
• CAS: 81721-74-6
• 化学式: C₁₉H₁₅NO₂
• 分子量: 289.334
• InChiKey: XTNSBPFEFLVLBC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  37.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  正丙胺 、 苯并[d]茚并[1,2-b]吡喃-5,11-二酮 在 水 、 Brine 、 magnesium sulfate 作用下， 以 氯仿 为溶剂， 反应 16.0h， 以to give a yellow-orange solid (0.32 g, 55%)的产率得到5,6-Dihydro-5,11-diketo-6-propyl-11H-indeno[1,2-c]isoquinoline
  参考文献：
  名称：

  Indenoisoquinolines as antineoplastic agents

  摘要：

  一些吲哚异喹啉被制备并在人类癌细胞培养物中评估其细胞毒性和对拓扑异构酶I的活性。最具细胞毒性的两种吲哚异喹啉被证明是顺式-6-乙基-5,6,12,13-四氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧代-11H-吲哚[1,2-c]异喹啉和顺式-6-烯丙基-5,6,12,13-四氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧代-(11H)吲哚[1,2-c]异喹啉。其中最有效的两种拓扑异构酶I抑制剂是6-(3-羧基-1-丙基)-5,6-二氢-5,11-二氧代-11H-吲哚[1,2-c]异喹啉(26)和6-乙基-2,3-二甲氧基-8,9-(亚甲二氧基)-11H-吲哚[1,2-c]异喹啉盐酸盐(27)。另外两种有效的拓扑异构酶I抑制剂，6-烯丙基-5,6-二氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧代-11H-吲哚[1,2-c]异喹啉(13c)和5,6-二氢-6-(4-羟基丁-1-基)-2,3-二甲氧基-8,9-亚甲二氧基-5,11-二氧代-(11H)-吲哚[1,2-c]异喹啉(19a)未解开DNA，也未影响拓扑异构酶II。

  公开号：

  US06509344B1

文献信息

• Indenoisoquinolines as antineoplastic agents
  申请人：The United States of America as represented by the Department of Health and Human Services

  公开号：US06509344B1

  公开（公告）日：2003-01-21

  A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity versus topoisomerase I. The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8,9(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-(11H)indeno[1,2-c]isoquinoline. Two of the most potent topoisomerase I inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2,3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27). Two additional potent topoisomerase I inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydoxybut-1-yl)-2,3-dimethoxy-8,9-methylenedioxy-5,11 dioxo-(11H)-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect topoisomerase II.

  已完成。已准备和评估了多种吲哚异喹啉类化合物在人类癌细胞培养物中的细胞毒性和对拓扑异构酶I的活性。其中两种最具细胞毒性的吲哚异喹啉被证明是顺式-6-乙基-5,6,12,13-四氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧基-11H-吲哚[1,2-c]异喹啉和顺式-6-烯丙基-5,6,12,13-四氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧基-(11H)吲哚[1,2-c]异喹啉。其中两种最有效的拓扑异构酶I抑制剂分别是6-(3-羧基-1-丙基)-5,6-二氢-5,11-二氧基-11H-吲哚[1,2-c]异喹啉 (26) 和6-乙基-2,3-二甲氧基-8,9-(亚甲二氧基)-11H-吲哚[1,2-c]异喹啉盐酸盐 (27)。另外两种强效的拓扑异构酶I抑制剂，6-烯丙基-5,6-二氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧基-11H-吲哚[1,2-c]异喹啉 (13c) 和 5,6-二氢-6-(4-羟基丁-1-基)-2,3-二甲氧基-8,9-亚甲二氧基-5,11-二氧基-(11H)-吲哚[1,2-c]异喹啉 (19a)，未对DNA进行解旋，也不影响拓扑异构酶II。
• indenoisoquinolines as topoisomerase inhibitors I useful as antineoplastic agents
  申请人：Purdue Research Foundation

  公开号：EP2050452A1

  公开（公告）日：2009-04-22

  A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity vs. topoisomerase I. The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-(11H)indeno[1,2-c]isoquinoline. Two of the most potent topoisomerase I inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2,3-dimethoxy-8,9-(methylenedioxy)11H-indeno[1,2-c]isoquinolinium chloride (27). Two additional potent topoisomerase I inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)-2,3-dimethoxy-8,9-methylenedioxy-5,11-dioxo-(11H)indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect topoisomerase II.

  研究人员制备了多种茚并异喹啉，并对其在人类癌细胞培养物中的细胞毒性以及对拓扑异构酶 I 的活性进行了评估。结果表明，两种细胞毒性最强的茚异喹啉分别是顺式-6-乙基-5,6,12,13-四氢-2,3-二甲氧基-8,9-（亚甲基二氧基）-5,11-二氧代-11H-茚并[1、2-c]异喹啉和顺式-6-烯丙基-5,6,12,13-四氢-2,3-二甲氧基-8,9-（亚甲基二氧基）-5,11-二氧代-11H-茚并[1,2-c]异喹啉。两种最有效的拓扑异构酶 I 抑制剂是 6-(3-羧基-1-丙基)-5,6-二氢-5,11-二氧代-11H-茚并[1,2-c]异喹啉（26）和 6-乙基-2,3-二甲氧基-8,9-(亚甲二氧基)11H-茚并[1,2-c]异喹啉氯化铵（27）。另外两种强效拓扑异构酶 I 抑制剂是 6-烯丙基-5,6-二氢-2,3-二甲氧基-8,9-（亚甲基二氧基）-5,11-二氧代-11H-茚并[1,2-c]异喹啉（13c）和 5、6-(4-羟基丁-1-基)-2,3-二甲氧基-8,9-亚甲基二氧基-5,11-二氧代-11H-茚并[1,2-c]异喹啉（19a）不会解开 DNA，也不会影响拓扑异构酶 II。
• Method for preparing indenoisoquinoline derivatives
  申请人：NATIONAL TAIWAN NORMAL UNIVERSITY

  公开号：US10336704B2

  公开（公告）日：2019-07-02

  A method for preparing indenoisoquinoline derivatives represented by the following formula (I) is disclosed, which comprises the following steps: (A) providing a first reactant represented by the following formula (II) and a second reactant represented by the following formula (III): and (B) reacting the first reactant represented by the formula (II) and the second reactant represented by the formula (III) in a solvent and selectively adding R2NH2 therein, to obtain the indenoisoquinoline derivatives represented by the formula (I), wherein, R1, R2, R3, A, X, Y, Z, m and n are defined in the specification.

  本发明公开了一种制备下式（I）所代表的茚并异喹啉衍生物的方法，该方法包括以下步骤： (A) 提供下式（II）代表的第一反应物和下式（III）代表的第二反应物： 和 (B) 将式（II）代表的第一反应物和式（III）代表的第二反应物在溶剂中反应，并在其中选择性地加入 R2NH2，得到式（I）代表的茚并异喹啉衍生物，其中，R1、R2、R3、A、X、Y、Z、m 和 n 在说明书中定义。
• WAWZONEK, S., ORG. PREP. AND PROCED. INT., 1982, 14, N 3, 163-168
  作者：WAWZONEK, S.

  DOI：——

  日期：——
• MICROVESICLE HISTONE H2AX AS A BIOMARKER FOR GENOTOXIC STRESS
  申请人：Pioma Inc.

  公开号：EP2971282B1

  公开（公告）日：2018-09-19